BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 33385426)

  • 1. Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis.
    Wijnands AM; de Jong ME; Lutgens MWMD; Hoentjen F; Elias SG; Oldenburg B;
    Gastroenterology; 2021 Apr; 160(5):1584-1598. PubMed ID: 33385426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
    De Jong ME; Van Tilburg SB; Nissen LHC; Kievit W; Nagtegaal ID; Horjus CS; Römkens TEH; Drenth JPH; Hoentjen F; Derikx LAAP
    J Crohns Colitis; 2019 Dec; 13(12):1485-1491. PubMed ID: 31175827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal Strictures in Patients With Inflammatory Bowel Disease Do Not Independently Predict Colorectal Neoplasia.
    Axelrad JE; Faye A; Slaughter JC; Harpaz N; Itzkowitz SH; Shah SC
    Inflamm Bowel Dis; 2022 Jun; 28(6):855-861. PubMed ID: 34319381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies.
    Zheng HH; Jiang XL
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):383-90. PubMed ID: 26938805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline Adherence.
    Burke KE; Nayor J; Campbell EJ; Ananthakrishnan AN; Khalili H; Richter JM
    Dig Dis Sci; 2020 Jan; 65(1):111-118. PubMed ID: 31367882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease.
    Shah SC; Ten Hove JR; Castaneda D; Palmela C; Mooiweer E; Colombel JF; Harpaz N; Ullman TA; van Bodegraven AA; Jansen JM; Mahmmod N; van der Meulen-de Jong AE; Ponsioen CY; van der Woude CJ; Oldenburg B; Itzkowitz SH; Torres J
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1106-1113.e3. PubMed ID: 29378311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No Association Between Pseudopolyps and Colorectal Neoplasia in Patients With Inflammatory Bowel Diseases.
    Mahmoud R; Shah SC; Ten Hove JR; Torres J; Mooiweer E; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH;
    Gastroenterology; 2019 Apr; 156(5):1333-1344.e3. PubMed ID: 30529584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon.
    Ullman T; Odze R; Farraye FA
    Inflamm Bowel Dis; 2009 Apr; 15(4):630-8. PubMed ID: 18942763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental Risk Factors for Inflammatory Bowel Diseases: An Umbrella Review of Meta-analyses.
    Piovani D; Danese S; Peyrin-Biroulet L; Nikolopoulos GK; Lytras T; Bonovas S
    Gastroenterology; 2019 Sep; 157(3):647-659.e4. PubMed ID: 31014995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK; Rutter MD
    World J Gastroenterol; 2012 Aug; 18(29):3839-48. PubMed ID: 22876036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies.
    Lutgens MW; van Oijen MG; van der Heijden GJ; Vleggaar FP; Siersema PD; Oldenburg B
    Inflamm Bowel Dis; 2013; 19(4):789-99. PubMed ID: 23448792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Indefinite Dysplasia and Advanced Neoplasia in Patients With Inflammatory Bowel Diseases Undergoing Surveillance.
    Mahmoud R; Shah SC; Torres J; Castaneda D; Glass J; Elman J; Kumar A; Axelrad J; Harpaz N; Ullman T; Colombel JF; Oldenburg B; Itzkowitz SH
    Clin Gastroenterol Hepatol; 2020 Jun; 18(7):1518-1527.e3. PubMed ID: 31446183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of Colorectal Cancer in Inflammatory Bowel Disease - the Evolving Landscape.
    Linson EA; Hanauer SB
    Curr Gastroenterol Rep; 2021 Aug; 23(9):16. PubMed ID: 34338892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Appendectomy and Risk of Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: A Nationwide Population-based Cohort Study.
    Mark-Christensen A; Kristiansen EB; Myrelid P; Laurberg S; Erichsen R
    Inflamm Bowel Dis; 2024 Jun; 30(6):877-883. PubMed ID: 37523678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
    Rossi RE; Conte D; Massironi S
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):123-31. PubMed ID: 26636407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of "indefinite for dysplasia" in inflammatory bowel disease: correlation with DNA flow cytometry and other risk factors of colorectal cancer.
    Choi WT; Rabinovitch PS; Wang D; Westerhoff M
    Hum Pathol; 2015 Jul; 46(7):939-47. PubMed ID: 25962315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV
    Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin Exposure Is Not Associated with Reduced Prevalence of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease.
    Shah SC; Glass J; Giustino G; Hove JRT; Castaneda D; Torres J; Kumar A; Elman J; Ullman TA; Itzkowitz SH
    Gut Liver; 2019 Jan; 13(1):54-61. PubMed ID: 30400722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal Cancer in Inflammatory Bowel Diseases: A Population-Based Study in Utah.
    Jewel Samadder N; Valentine JF; Guthery S; Singh H; Bernstein CN; Wan Y; Wong J; Boucher K; Pappas L; Rowe K; Bronner M; Ulrich CM; Burt RW; Curtin K; Smith KR
    Dig Dis Sci; 2017 Aug; 62(8):2126-2132. PubMed ID: 28050782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel disease: a meta-analysis.
    Jess T; Lopez A; Andersson M; Beaugerie L; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1793-1800.e1. PubMed ID: 24907505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.